<code id='4B22BBCCD7'></code><style id='4B22BBCCD7'></style>
    • <acronym id='4B22BBCCD7'></acronym>
      <center id='4B22BBCCD7'><center id='4B22BBCCD7'><tfoot id='4B22BBCCD7'></tfoot></center><abbr id='4B22BBCCD7'><dir id='4B22BBCCD7'><tfoot id='4B22BBCCD7'></tfoot><noframes id='4B22BBCCD7'>

    • <optgroup id='4B22BBCCD7'><strike id='4B22BBCCD7'><sup id='4B22BBCCD7'></sup></strike><code id='4B22BBCCD7'></code></optgroup>
        1. <b id='4B22BBCCD7'><label id='4B22BBCCD7'><select id='4B22BBCCD7'><dt id='4B22BBCCD7'><span id='4B22BBCCD7'></span></dt></select></label></b><u id='4B22BBCCD7'></u>
          <i id='4B22BBCCD7'><strike id='4B22BBCCD7'><tt id='4B22BBCCD7'><pre id='4B22BBCCD7'></pre></tt></strike></i>

          leisure time

          leisure time

          author:Wikipedia    Page View:7
          Nasdaq
          Mario Tama/Getty Images

          Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

          The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

          advertisement

          The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more
          Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable
          Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

          CTscansshowedthatthepatientinitiallyrespondedtolorlatinib(left).Buteightmonthslater,themetastaticliv

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          Study: Why relieving medical debt did not improve financial outcomes

          AdobePhilanthropistsandfoundationsliketheoneIworkfortakealotofcalculatedrisks.Weinvestinresearch,adv